INOFEA AG was founded in February 2014 in Basel by a group of entrepreneurs and scientists as a spin-off from the School of Life Sciences, University of Applied Sciences and Arts, North- Western Switzerland (FHNW). The company was created to meet a critical need of the industry: to make enzymes more stable, re-usable and suitable for continuous processes. INOFEA AG owns a patented technology to immobilize enzymes and protect them with a tailor-made shield making them easy to use in biocatalysis, bioanalysis, proteomics and as an active ingredient for the pharmaceutical, chemical and consumer care industry.
Dr. Anne Timm
is the CEO of INOFEA AG since March 2019. She has a natural science background and spends more than 30 years mainly in the Chemical industry being familiar with a variety of applications and she has a broad connection to various industry players
Dr. Rita Correro
works as responsible of research and development, production and quality assurance at INOFEA AG since November 2017. After obtaining her PhD in biology from the the Swiss Federal Institute of Technology in Zurich (ETHZ) in 2011, she worked as postdoctoral research associate in the field of biocatalysis in the group of molecular nanotechnology at the FHNW. During this time frame, she pioneered the development of enzyme shielding on nanoparticles which has evolved into the enzzen® technology.
Dr. Carolina Giunta
graduated in Physical Chemistry at the University of Palermo (Italy) with a thesis on nanotechnology applied to solar cells. Afterward, she graduated with a Ph.D. in chemistry in the field of enzyme bioconjugation at the University of Basel (Switzerland) during which she had the possibility to apply the technology patented by INOFEA for developing enzymes able to function in extreme environments. Carolina has a deep experience in the application of the enzzen®-technology for empowering enzymes. Since 2021, Carolina is working at INOFEA in the role of Project Leader.